About us
Our team is a rare combination of technology entrepreneurs, distinguished scientists, and investment experts who are also active members of a community of over 3,000 med-biotech founders from BRICS markets who have built more than 30 unicorns.
Our focus
We invest our experience and expertise in talented teams and outstanding developments in the med-biotech sector. Healthcare spending continues to grow rapidly. Genome Capital believes that now is the right time to invest in:
- Medical robots
- AI diagnostics
- Telemedicine
- Neurotechnology
- Bioimplants